“We recognize that our products play a key role in patient care and are crucial for the management of hospitalized COVID-19 patients. As such, everyone at IL understands our role and is committed to maintain our customers’ operations.”

—Ramon Benet, CEO at IL

An update on the IL response to COVID-19 from our CEO


A Clinical Perspective on Hemostasis and Viscoelastic Testing During COVID-19

View Here


Managing POCT During COVID-19: Insights from a Large Reference Laboratory

View Here


“IL was very helpful in optimizing our hospital system’s COVID-19 response.  Early in the pandemic, we were concerned about our ability to meet the 30% increase in blood-gas testing demand. We considered ordering a surplus of GEM PAK cartridges for the GEM Premier systems throughout our system. Instead, IL proposed an alternative option to increase the test size of our GEM PAKs. This flexibility allowed us to increase our testing capacity without increasing our reagent-storage capacity, and ultimately saved our system thousands of dollars.”


—Lois Schultz, POCT Technical Coordinator at University Hospitals Cleveland Medical Center

Werfen Academy



Featuring new ISTH webinars on Hemostasis and COVID-19

We are offering five new webinars from the ISTH related to COVID-19:

  • Thrombosis, Thromboprophylaxis and Coagulopathy in COVID-19 Infections
  • Thrombotic and Hemostatic Issues in Critical Care Units Managing COVID-19
  • Thrombosis in the Hospitalized COVID Positive Patient
  • COVID-19 Hypercoagulability
  • Coagulopathy and Thromboembolism in COVID-19 Patients in Special Populations

IL Employees Dedicated to Uninterrupted Product Supply and Customer Support



Thank you, Operations and Field Support teams for your dedication during COVID-19!